Thymosin Alpha-1

• 10mg lyophilized peptide

• T-cell support and activation: Associated with promoting T-cell production, maturation, and activation, which are central to adaptive immune response.
• Immune modulation and inflammation balance: Studied for helping balance pro inflammatory and anti inflammatory signaling, which may support pathogen clearance in certain models.
• Autoimmune response modulation: Explored for its ability to modulate immune activity and support immune homeostasis in dysregulated immune states.

TA-1 has been studied for

• Immune system support: Often studied in immune compromised contexts such as chronic infections, autoimmune conditions, or during chemotherapy.
• Chronic infection management: Investigated for supporting immune response in chronic viral infection models including HIV, hepatitis B, and hepatitis C.
• Cancer immunotherapy adjunct: Used in some research as an adjuvant approach intended to help immune recognition and targeting of tumor cells.

• Thymosin Alpha-1 is generally described as well tolerated in the literature, with relatively few reported adverse effects.
• Potential observations include mild injection site reactions (redness, swelling, irritation) and rare transient flu like symptoms such as mild fatigue or muscle aches.
• Because TA-1 can enhance immune activity, individuals with autoimmune conditions are typically advised to use it only under medical supervision to avoid excessive immune stimulation.